Whether you’re advancing an early-stage program, preparing for clinical development, or scaling toward commercial manufacturing, Agilent Advanced Therapeutics is ready to support your next step.
Our specialty CDMO capabilities span oligonucleotides, biologics, complex chemistry, highly potent APIs, bioreagents, and supporting services.
Tell us about your program, manufacturing needs, or technical challenges, and our team will connect you with the right experts.
Complete the form to start a conversation with our team.